The New Paradigm of Precision Medicine for the Management of Advanced Systemic Mastocytosis

Advanced systemic mastocytosis is a rare diagnosis, yet treatment options are increasing with new FDA approvals. In this commentary, I review current treatments and the most clinically important studies on advanced systemic mastocytosis from ASH 2021.

Daniel J. DeAngelo, MD, PhD Released: February 18, 2022

Despite the rarity of systemic mastocytosis, multiple therapies are available to manage advanced disease. In this commentary, I review key data on current treatment options and how I individualize therapy for patients with advanced systemic mastocytosis.

Prithviraj Bose, MD Released: April 21, 2022